← Back to patent-cliff list
CAS 635702-60-2
2,3-dimethyl-2H-indazol-6-amine hydrochloride
Codes: PAZO-005
Application context (from source-drug indications)
Renal cell carcinomaPazopanib HydrochlorideSarcomaPazopanib HydrochlorideSoft tissue neoplasmPazopanib HydrochlorideEpistaxisPazopanib HydrochlorideHereditary haemorrhagic telangiectasiaPazopanib HydrochlorideSolitary fibrous tumourPazopanib Hydrochloride
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Pazopanib Hydrochloride | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2-ethylaniline→2-ethyl-5-nitroaniline→3-methyl-6-nitro-1H-indazole→2,3-dimethyl-6-nitro-2H-indazole→2,3-dimethyl-2H-indazol-6-amine hydrochloride→2,4-dichloropyrimidine→N-(2-chloropyrimidin-4-yl)-2,3-dimethyl-2H-indazol-6-amine→N-(2-chloropyrimidin-4-yl)-N,2,3-trimethyl-2H-indazol-6-amine→5-amino-2-methylbenzenesulfonamide
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Qualified Partner — East China API Works | 2,3-Dimethyl-2H-indazol-6-amine hydrochloride Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.